Events

Wellbeing at Work Summit w/ Rohan Kallicharan

Panel Discussion: Successful International Wellbeing Strategies

5th November | 9:50 - 10.25

Join BenevolentAI’s HR Director and Mind campaigner, Rohan for a panel discussion on the secrets to achieving international wellbeing strategy success.

Register →


Rohan Kallicharan
HR Director

Rohan is HR Director at BenevolentAI and an ambassador for Mind, the mental health charity. He has advised a number of high profile companies on their mental wellbeing strategy, as well as involvement in national campaigns to raise awareness around mental health.Recently, he has worked with the FA, Heads Together and Kensington Palace, speaking to Sky News, the BBC and ITV about his own journey from severe mental illness and homelessness to advocacy, and championing the significant role of sport and football in breaking down barriers in talking about mental wellbeing, especially for young men.

More Posts

You Might Also Like

Blog
Intern at BenevolentAI part I: meet our 2020 intern cohort
What impactful work did our interns get up to across Engineering, Data Science, ML and business operations this summer? Get to know them and their work in our tech internships blog.
Nov 26, 2020
News
FDA grants Emergency Use Authorisation for baricitinib in hospitalised COVID-19 patients nine months after initial hypothesis was published by BenevolentAI
BenevolentAI scientists first identified baricitinib as a potential treatment for COVID-19 in early February 2020 using Benevolent's AI tools and biomedical knowledge graph.
Nov 20, 2020
News
BenevolentAI at NeurIPS 2020: Machine Learning in Drug Discovery
BenevolentAI is happy to announce it is sponsoring NeurIPS 2020. Join us to hear about data diversity and ML applied drug discovery, and to learn about careers in the field.
Nov 17, 2020
Blog
Careers with Impact: 5 learnings from machine learning applied drug discovery
Last week, we brought together four of our exceptional colleagues for a panel discussion on careers in machine learning applied drug discovery. Here are some of our main takeaways:
Nov 17, 2020
Blog
Data published in Science Advances shows baricitinib reduces COVID-19 morbidity and mortality
Research published in Science Advances supports BenevolentAI’s AI-generated hypothesis from late January for baricitinib as a treatment for COVID-19.
Nov 13, 2020
News
Sir Nigel Shadbolt joins BenevolentAI as a non-executive director
BenevolentAI strengthens its Board with the appointment of AI pioneer Sir Nigel Shadbolt as Non-Executive Director.
Nov 3, 2020